Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT02913794 Completed - Clinical trials for Cardiovascular Diseases

Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

FIMARO
Start date: October 11, 2016
Phase:
Study type: Observational

Fimasartan and Rosuvastatin for hypertension and dyslipidemia control

NCT ID: NCT02913339 Completed - Clinical trials for Cardiovascular Disease

mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.

mHealth
Start date: August 24, 2016
Phase: N/A
Study type: Interventional

Cardiovascular disease (CVD) accounts for approximately one-third of Argentina's deaths. Despite the availability of management and treatment for CVD which is offered to the uninsured population at government primary care clinics (PCCs), the rates at which those at risk are screened, identified and referred to the clinics are very low. This study will determine if providing CHWs with an mHealth application using an integrated, inexpensive and validated screening tool on cell phones for screening in the community which is linked with the PCC scheduling system wirelessly allowing the CHWs to make appointments at the time they identify high-risk individuals, will increase the number of referral and follow-up visits that patients attend at the PCCs.

NCT ID: NCT02913144 Completed - Clinical trials for Cardiovascular Disease

7 Year Follow-up Study of the DanRisk Population

Start date: May 2014
Phase: N/A
Study type: Observational [Patient Registry]

OBJECTIVES: To investigate the incidence of cardiovascular events as well as progression of coronary artery calcium (CAC) in healthy middle-aged subjects over a period of 7 years, and the relation to traditional as well as new cardiovascular risk factors. METHODS: The Danrisk cohort was established in 2009-2010 based on random retrieval from the Danish national civil registry (N=1825). Initially, distribution of gender, area of residence and year of birth (1949 or 1959) were equal among the 4 involved centres (OUH, Svendborg, Vejle and Esbjerg). A total of 1257 subjects (69%) accepted the invitation to undergo cardiovascular risk evaluation including non-contrast enhanced cardiac CT-scan for CAC estimation, and a total of 1227 subjects were found free of cardiovascular disease (CVD) and diabetes (DM), and was included in the study back then. In 2014-2015 the DanRisk cohort was invited to a 5 year follow-up examination. The investigators examined a total of 1031 subjects (82%) in the investigators 4 regional centres. The follow-up examination included general health evaluation and estimation of CAC by non-contrast enhanced cardiac CT-scan. Information of death, cardiovascular events and medication usage was obtained from the Danish national patient register, the Danish register of causes of death and the Danish national database of reimbursed prescriptions in 2016.

NCT ID: NCT02907684 Completed - Clinical trials for Cardiovascular Disease

The Impact of Almond Nut Consumption on Markers of CVD & Metabolic Health

Almonds
Start date: March 29, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the cardio-metabolic health effects of consuming almond nuts in place of habitual (usual) snack products in adults at moderate risk of developing cardiovascular disease

NCT ID: NCT02903433 Completed - Clinical trials for Cardiovascular Disease

Effects of Avocado Intake on the Nutritional Status of Families

Start date: April 20, 2017
Phase: N/A
Study type: Interventional

Avocados are an excellent source of fiber, potassium, magnesium, and poly- and mono-unsaturated fats. They can be a nutrient dense component of healthful dietary patterns and have the potential to improve the cardiovascular disease (CVD) risk profiles of families in the United States (US). The proposed research plan will focus on the contribution of avocado intake to the reduction in CVD risk of US families, by examining the effects of avocado intake on the overall nutritional status of families. Of particular interest is establishing these effects in ethnic populations such as Hispanics/Latinos. On average, Hispanic/Latinos are at increased risk for metabolic diseases that predispose to CVD. This 6-month cluster randomized trial in Hispanic/Latino Americans aims to accurately determine the impact of avocados on the overall dietary pattern of their families. Future research will extend the results of the current trial to a larger sample of ethnically diverse families in order to evaluate whether sustained changes occur in nutritional, cardiovascular and metabolic health status.

NCT ID: NCT02902913 Completed - Clinical trials for Cardiovascular Diseases

Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity

Start date: January 2015
Phase: N/A
Study type: Interventional

Data from limited dietary intervention trials suggest that the cardiovascular health benefit of extra virgin olive oil (EVOO) may increase with phenolic content. However, while EVOOs contain an array of bioactive compounds, little information exists regarding the physiological effects of specific chemical species. Among the EVOO-derived phenolics with demonstrated anti-inflammatory effects in animal and in vitro models is oleocanthal, an inhibitor of cyclooxygenase (COX). The current study compared the impact of acute intake (40 mL) of EVOO on platelet reactivity in healthy adult males (n=9). The volunteers were randomly assigned to consume three EVOOs in a double-blind controlled trial. The EVOO were characterized and chosen for equivalency in their total phenolic content and fatty acid profiles, but differing in their oleocanthal to oleacein ratio.

NCT ID: NCT02899442 Completed - Clinical trials for Cardiovascular Diseases

Cardiovascular Risk Prevention Among Night Workers

Heart-Of-Night
Start date: September 2015
Phase: N/A
Study type: Interventional

With around 15 to 20% of workforce engaging in nightshift work in modern society for obvious economic and social reasons, the consequences of night work on cardiovascular risks are substantial. Compared to day workers, it was reported higher risks of cardiovascular diseases (estimated at 40%) and of metabolic syndrome (1.5 times) in shift workers. The occurrence of metabolic syndrome increases the risk to develop high blood pressure, diabetes and cardiovascular events. Because some characteristics of night work are potentially modifiable, some preventive strategies could be applied to reduce its adverse effects. For shift workers, some recent guidelines (High Health Authority, 2012 & 2016) and fruitful literature propose to develop regular assessments of cardiovascular risk factors and occupational activities, and stress the need to expand preventive strategies. Moreover, some recent French laws provide an opportunity to implement preventive interventions and specific monitoring through the occupational physicians network. However, whether the concept is defined, the exact content, method and the potential benefits are unknown. The investigator assume that individual advice related to collective countermeasures referenced on guidelines (applied on worksite within plant) could lead a better improvement on incidence of metabolic syndrome compared to those that benefit only individual advice. Main objective: To measure the benefit from implementation of individual and collective prevention (dispensed in worksites within plants) on metabolic syndrome compared to strategy relying only on individual prevention among night workers, over 2 years' follow-up. The secondary objectives of the study are to evaluate in both groups: 1. Observance of different types of preventive strategies 2. Impact of observance of preventive advice on metabolic syndrome in shift workers and on each component of metabolic syndrome 3. Determinants which promote the up-take of preventive strategies among night workers 4. The countermeasures which could be applied and effective within company 5) Medico-economic assessment is planned from an ancillary study.

NCT ID: NCT02890927 Completed - Clinical trials for Cardiovascular Diseases

Geriatric-CO-mAnagement for Cardiology Patients in the Hospital

G-COACH
Start date: September 2016
Phase: N/A
Study type: Interventional

The primary objective of the evaluation study is to determine if geriatric co-management is superior to standard of care in preventing functional decline in older patients admitted for acute heart disease or Transcatheter Aortic Valve Implementation (TAVI) to the cardiology units of the University Hospitals Leuven.

NCT ID: NCT02889822 Completed - Clinical trials for Cardiovascular Diseases

The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

Start date: March 2010
Phase: Phase 1
Study type: Interventional

Conducted in Chinese healthy adult volunteers,the study aims to observe the safety and tolerability of single/multiple-dose administration of different doses of Alprostadil Liposome for Injection as well as to confirm the safety dose range.

NCT ID: NCT02889653 Completed - Clinical trials for Cerebrovascular and Cardiovascular Diseases

The Bleeding With Antithrombotic Therapy Study 2

BAT2
Start date: October 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.